However, although many studies had focused on the possible therapeutic effects of TRAIL and its receptor DR5 in related diseases such as cancer and virus or inflammation-related disease, the role of TRAIL-DR5 pathway in ARS is unclear. The gene discussed is TNFSF10; the disease is Axenfeld-Rieger syndrome.